Effect of albumin infusion in patients with predicted severe acute pancreatitis: A randomized controlled trial
Pancreatology · 2025-09 · 25 (6) · 817-822
DOI: 10.1016/j.pan.2025.08.012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pancreatology, 2025-09. Verfasst von Wenqing Shu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Diges…. Hauptthemen laut MEDLINE: Pancreatitis, Albumins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
BACKGROUND: Although previous studies have shown the potential advantages of albumin administration in critically ill patients, it has not been tested in patients with severe acute pancreatitis. METHODS: In this single-center trial, we randomly assigned 60 patients with acute pancreatitis in the intensive care unit (ICU) to receive 5 % albumin and crystalloid solution or crystalloid solution alone. Patients in the albumin group received 30 g of 5 % albumin daily within the first 3 days of admission. The primary endpoint was remission of SIRS on Day 3 and the co-primary outcome was all-cause mortality 60 days after discharge. RESULTS: No significant differences in patient characteristics, time of admission, degree of organ failure at admission, vital signs, biochemical indicators or total daily amount of administered fluid (P > 0.05) were detected between the two groups. There were also no significant differences between the patients in the crystalloid group and those in the albumin group regarding SIRS remission and 60-day mortality. However, the incidence of sepsis in the albumin group was lower than that in the crystalloid group (10 % vs. 36.7 %, respectively; P = 0.01). CONCLUSION: In our study, albumin replacement did not reduce the remission rate of SIRS or the rate of mortality at 60 days in patients with acute pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Department of Respiratory and Critical Care Medicine, The Jingdezhen Second People's Hospital, China.
- Department of Critical Care Medicine, The First Affiliated Hospital, Nanchang University, China.
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Shu, W., Wan, J., Xu, H., Liu, F., Zeng, Z., Zhu, Y., Lu, N., & Xia, L. (2025). Effect of albumin infusion in patients with predicted severe acute pancreatitis: A randomized controlled trial. Pancreatology, 25(6), 817-822. https://doi.org/10.1016/j.pan.2025.08.012
Vancouver
Shu W, Wan J, Xu H, Liu F, Zeng Z, Zhu Y, et al. Effect of albumin infusion in patients with predicted severe acute pancreatitis: A randomized controlled trial. Pancreatology. 2025;25(6):817-822. doi:10.1016/j.pan.2025.08.012
BibTeX
@article{Shu2025,
author = {Shu, Wenqing and Wan, Jianhua and Xu, Huiting and Liu, Fen and Zeng, Zhengguo and Zhu, Yin and Lu, Nonghua and Xia, Liang},
title = {Effect of albumin infusion in patients with predicted severe acute pancreatitis: A randomized controlled trial},
journal = {Pancreatology},
year = {2025},
volume = {25},
number = {6},
pages = {817--822},
doi = {10.1016/j.pan.2025.08.012}
}
EUVIMED